The sites where our bodies come into contact with the outside world—via skin, the surface of the eye, inside the mouth, the lining of the intestine and the urinary tract, for example—are known as barrier tissues.

Helping to defend those tissues are innate lymphoid cells, or ILCs, which when faced with a threat, stimulate proteins called cytokines that further activate the immune system and control the intestinal microbiome.

These cells naturally diminish with aging or can be depleted by certain medical conditions.

ILCs are made inside bone marrow and circulate in the blood. But how are they activated to mobilize and travel to their target sites to replenish the depleted pool of tissue ILCs?

A Michigan Medi...

A research team has successfully developed a catalyst coating technology that significantly improves the performance of solid oxide fuel cells (SOFCs) in just four minutes.

Dr. Yoonseok Choi from the Hydrogen Convergence Materials Laboratory at the Korea Institute of Energy Research (KIER), in collaboration with Professor WooChul Jung from the Department of Materials Science and Engineering at KAIST and Professor Beom-Kyung Park from the Department of Materials Science and Engineering at Pusan National University, led the research.

Their findings were published in Adva...

A team of scientists used NASA’s James Webb Space Telescope to parse the composition of the Crab Nebula, a supernova remnant located 6,500 light-years away in the constellation Taurus...

Eczema, a skin inflammatory disease that causes dry, itchy and inflamed skin, affects millions worldwide. Eczema is associated with an altered skin microbiome and higher colonization by Staphylococcus aureus.

A study, led at New York Medical by postdoctoral fellow Anish R. Maskey, Ph.D., focuses on the natural compound berberine and its impact on eczema exacerbated by S. aureus. The findings, presented at ASM Microbe, shed light on berberine’s ability to inhibit S. aureus colonization and alleviate eczema symptoms without adverse effects.

Current treatments often fall short—topical antibiotics can give temporary relief, but risk development of antibiotic resistance, and steroid use can potentially result in topical steroid withdrawal (TSW) syndrome...